Domov › Glioblastóm › Texas › Houston
Klinické štúdie Glioblastóm v meste Houston, TX
26 štúdií pre Glioblastóm hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Prebieha náborFáza 3
- University of Texas Houston Health Science Center, Houston
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Prebieha náborFáza 2/3
- University of Texas - MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Prebieha náborFáza 1
- Baylor St. Luke's Medical Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Prebieha náborFáza 1
- M D Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Prebieha náborFáza 1/2
- Baylor College of Medicine, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Prebieha náborFáza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Prebieha náborFáza 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Prebieha náborObservačná štúdia
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Prebieha náborFáza 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Prebieha náborFáza 3
- MD Anderson Cancer Center, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Prebieha náborFáza 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Prebieha náborFáza 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Prebieha náborFáza 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
Prebieha náborVítaní zdravých dobrovoľníkov
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Prebieha náborFáza 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Prebieha náborFáza 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Prebieha náborSkorá fáza 1Vítaní zdravých dobrovoľníkov
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Prebieha náborFáza 2
- Texas Children's Hospital, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Prebieha náborFáza 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Prebieha náborFáza 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Prebieha náborFáza 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Prebieha náborFáza 1
- UT MD Anderson Cancer Center, Houston
Štúdie Glioblastóm v iných mestách
- New York City, NY30 štúdií
- Boston, MA28 štúdií
- Los Angeles, CA24 štúdií
- Durham, NC20 štúdií
- San Francisco, CA17 štúdií
- Chicago, IL15 štúdií
- Washington, DC15 štúdií
- Columbus, OH14 štúdií
- Miami, FL14 štúdií
- Rochester, MN13 štúdií
- Jacksonville, FL13 štúdií
- Aurora, CO12 štúdií
Iné štúdie v Houston
- Nemalobunkový karcinóm pľúc145 štúdií
- Rakovina prsníka126 štúdií
- Rakovina (všetky typy)121 štúdií
- Metastatická rakovina104 štúdií
- Kolorektálny karcinóm102 štúdií
- Rakovina vaječníkov89 štúdií
- Akútna myeloidná leukémia85 štúdií
- Rakovina pľúc78 štúdií
- Rakovina prostaty76 štúdií
- Rakovina endometria68 štúdií
- Rakovina pankreasu61 štúdií
- Melanóm59 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.